Open Beta
MetriLume

US marketsBHC

SEC-sourced researchBeta

BHC

Bausch Health Companies Inc.

Company comparison ↗

Data passport

CIK
0000885590
Exchange
NYSE
Business activity
Pharmaceutical Preparations · SIC 2834
Financial inputs
6/6
Filing date
Oct 29, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2023: 8,757,000,000.0000 USD; December 2024: 9,625,000,000.0000 USD; December 2025: 10,266,000,000.0000 USD10.3B USD0 USD0December 2023December 2024December 2025
BHC · Exact amounts and source periods · USD
Period endRevenueFiling date
December 20238,757,000,000.0000Feb 19, 2026
December 20249,625,000,000.0000Feb 19, 2026
December 202510,266,000,000.0000Feb 19, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 202510,266,000,000.0000157,000,000.00001,400,000,000.000026,366,000,000.000025,989,000,000.0000Feb 19, 2026
December 20249,625,000,000.0000-46,000,000.00001,597,000,000.000026,523,000,000.000026,845,000,000.0000Feb 19, 2026
December 20238,757,000,000.0000-592,000,000.00001,032,000,000.0000——Feb 19, 2026

Explainable fundamental score

Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.

58/100
Profitability53
Growth57
Balance sheet1
Cash generation77
Data coverage100

Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$10.27BJan 1, 2025 – Dec 31, 2025Feb 19, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$9.63BJan 1, 2024 – Dec 31, 2024Feb 19, 202610-K
Net incomeNetIncomeLoss$157MJan 1, 2025 – Dec 31, 2025Feb 19, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities$1.4BJan 1, 2025 – Dec 31, 2025Feb 19, 202610-K
Total assetsAssets$26.37BDec 31, 2025Feb 19, 202610-K
Total liabilitiesLiabilities$25.99BDec 31, 2025Feb 19, 202610-K

New filings

Explore methodology ↗